SET Nuclear Oncogene (SET) Peptide
Quick Overview for SET Nuclear Oncogene (SET) Peptide (ABIN939297)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- IDEVQNEIDR LNEQASEEIL KVEQKYNKLR QPFFQKRSEL IAKIPNFWVT
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SET antibody,
Alternative Names: SET control peptide, SET antibody Blocking Peptide, Anti-SET Blocking Peptide, Set Nuclear Oncogene Blocking Peptide, 2PP2A Blocking Peptide, I2PP2A Blocking Peptide, IGAAD Blocking Peptide, PHAPII Blocking Peptide, TAF-IBETA Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Background
- SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1.
-
Molecular Weight
- 32 kDa
Target
-